For the Inventor, By the Inventor

Enter inventor name

Des Moines, IA, United States of America

Truc Minh Nguyen

USPTO Granted Patents = 20 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 227(Granted Patents)

Location History:

Des Moines, IA (US) (2010 - 2012)
New York, NY (US) (2007 - 2014)

Company Filing History:

Memory Pharmaceuticals Corporation

Memory Pharmaceutical Corporation

Years Active: 2007-2014

Loading Chart...

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8691841 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof (2014-04-08),

2. 8486937 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof (2013-07-16),

3. 8263619 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof (2012-09-11),

4. 8252811 - Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof (2012-08-28),

5. 8158629 - Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof (2012-04-17),

6. 8134003 - Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof (2012-03-13),

7. 7994199 - Heterocyclic compounds, methods for the preparation thereof, and uses thereof (2011-08-09),

8. 7964600 - Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof (2011-06-21),

9. 7943773 - Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof (2011-05-17),

10. 7932248 - 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof (2011-04-26),

11. 7902217 - Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof (2011-03-08),

12. 7790722 - Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof (2010-09-07),

13. 7700630 - Heterocyclic compounds, methods for the preparation thereof, and uses thereof (2010-04-20),

14. 7696229 - Compounds having 5-HT6 receptor affinity (2010-04-13),

15. 7632831 - 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof (2009-12-15),

Title: Truc Minh Nguyen: Innovator in Nicotinic Acetylcholine Receptor Research

Introduction

Truc Minh Nguyen is a prominent inventor based in Des Moines, Iowa, recognized for his significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 20 patents, Nguyen focuses on developing novel compounds related to nicotinic acetylcholine receptors, which are crucial in treating various neurological disorders.

Latest Patents

Among his recent patents are groundbreaking innovations concerning indazoles, benzothiazoles, benzoisothiazoles, and benzisoxazoles. These inventions relate to the activation of nicotinic acetylcholine receptors (nACh receptors) and target diseases stemming from their dysfunction, particularly those affecting the brain. The novel compounds act as ligands for the α7 nACh receptor subtype and encompass methods for their preparation, associated compositions, and medical applications.

Career Highlights

Truc Minh Nguyen has had a notable career with significant roles in various organizations. He has worked with Memory Pharmaceuticals Corporation, playing a key role in developing innovative solutions for neurological disorders. His extensive patent portfolio underscores his commitment to advancing medical research and therapies.

Collaborations

Throughout his career, Nguyen has collaborated with talented individuals in the pharmaceutical field, including Wenge Xie and Ashok Tehim. These collaborations have fostered a dynamic exchange of ideas and have contributed to the advancements in research pertaining to nACh receptors.

Conclusion

Truc Minh Nguyen stands out as a pioneering inventor, with a strong focus on improving therapeutic approaches for conditions linked to nicotinic acetylcholine receptor malfunctions. His work not only exemplifies innovation in pharmaceutical sciences but also reflects a dedication to enhancing human health through research and development. The impact of his patents is expected to resonate in the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…